Zyme/protease M/neurosin/human kallikrein 6 (hK6) is a member of the human kallikrein family of trypsinlike serine proteinases and was originally identified as being down-regulated in metastatic breast and ovarian tumors when compared with corresponding primary tumors. Recent evidence suggests that hK6 may serve as a circulating tumor marker in ovarian cancers. In addition, it was described in the brain of Parkinson's disease and Alzheimer's disease patients, where it is implicated in amyloid precursor protein processing. It is thus a biomarker for these diseases. To examine the mechanism of activation of hK6, we have solved the structure of its proform, the first of a human kallikrein family member. The proenzyme displays a fold that exhibits chimeric features between those of trypsinogen and other family members. It lacks the characteristic "kallikrein loop" and forms the six disulfide bridges of trypsin. Pro-hK6 displays a completely closed specificity pocket and a unique conformation of the regions involved in structural rearrangements upon proteolytic cleavage activation. This points to a novel activation mechanism, which could be extrapolated to other human kallikreins.
In humans, tissue kallikrein gene family members consist of five coding exons and map in tandem to the same chromosomal locus (19q13.3-13.4) (5, 21) , which shows genetic linkage to Alzheimer's disease (22) and which is nonrandomly rearranged in a variety of human solid tumors, like pancreatic carcinomas, astrocytomas, ovarian cancers, and thyroid tumors, among others (23) (24) (25) . Distinct members of the kallikrein family have been associated with cancer, and two members, PSA and glandular kallikrein, are used as biomarkers for the diagnosis and monitoring of prostate and breast cancer, whereas kallikrein 11 has been assessed for ovarian carcinoma (26) .
Human kallikrein 6 (hK6) is a member of the kallikrein gene family, and it is also known as protease M, neurosin, or zyme (16, 27, 28) , a 223-amino acid serine proteinase with trypsinlike activity and restricted substrate specificity. It derives from a 244-amino acid precursor containing a 16-residue presignal peptide and a 5-amino acid activation propeptide and is glycosylated at Asn 132 . This protein may have orthologues in mouse, rat, and monkey (28 -31) . It is distinct from neuropsin (KLK8), a hippocampal protease involved in kindling epileptogenesis in mice (32) . Like the other members of the human kallikrein family, the KLK6 gene lies at chromosome locus 19q13.4, telomeric to the PSA (KLK3) and KLK2 genes (5, 21) . (Pro)hK6 or its mRNA was found in human brain, spinal cord, cerebellum, kidney, uterus, mammary gland, pancreatic tissue, cerebrospinal fluid, prostate and salivary glands and, at a lower level, in spleen (16, 27, 28, 33, 34) . Immunohistochemical localization of hK6 in various tissues, showing epithelial cell secretion, has been published (35) . It has also been detected in pathological tissues, as human colon adenocarcinoma and ovarian and breast cancer. In the metastatic breast tumor cell line BT474, estrogens and progestins up-regulate the expression of hK6 in a dose-dependent manner (36) . The connection between breast and prostate cancer and steroid hormones has been established in many epidemiological studies (37) . hK6 was shown to be down-regulated in the metastatic cells but strongly expressed, although less so than in normal tissues, in primary breast cancer cells, ovarian cancer tissue, and tumor cell lines, whereas no expression was detected in normal ovary (16) . Plasminogen was suggested as a putative target in the search for physiological substrates of hK6. Proteolytic cleavage of plasminogen in vitro resulted in the generation of angiostatin and angiostatin-like fragments. Angiostatin is an endogenous inhibitor of tumor angiogenesis and metastatic growth. Therefore, this expression pattern suggests that hK6 contributes to several cancers in establishing breast and ovarian primary tumors and that it may function later during tumor progression as a potential metastasis and angiogenesis inhibitor (16, 38) .
The protein has also been found in adult but not in fetal brain. It is decreased in Parkinson's disease and Alzheimer's disease patients (33) . Cells transfected with the enzyme and amyloid precursor protein accumulate amyloidogenic fragments (28) . Accordingly, hK6 has been implicated in the progression of Alzheimer's disease. This activity of hK6 in brain is consistent with the finding that its mRNA is induced in the perilesioned region upon injury of the central nervous system (39) . These results and the fact that hK6 has been found in significantly increased concentrations in the serum of ovarian cancer patients and in the cerebrospinal fluid, plasma, and blood of Alzheimer's disease patients have led to the development of an immunofluorometric assay for the measurement of this new biomarker for breast and ovarian cancer and for Alzheimer's disease (40 -42) .
hK6 is a serine proteinase expressed as an inactive zymogen to prevent proteolytic activity in the wrong environment. Upon adequate stimulation, limited proteolysis is induced, leading to proenzyme activation. For the first time, we have analyzed the proform of a member of the (human) kallikrein family by x-ray crystallography, since no three-dimensional structure of a prokallikrein was available. We present the essential features of the structural determinants for activation of human pro-hK6, which can be extrapolated to the other 14 members of the family.
EXPERIMENTAL PROCEDURES
Protein Preparation-Initial trials to produce homogenous protein including the residues of the chemical sequence of the hK6 precursor Ala 10 -Lys 245 (chymotrypsin numbering (18) ; corresponds to Ala 16 -Lys 244 of the sequential protein numbering (see Fig. 1 )) failed due to autolysis after Arg 76 . 2 Accordingly, this residue was mutated to glutamine. The N-glycosylation site at Asn 132 prevented the protein from crystallizing, so it was also replaced by glutamine. Finally, a further mutation occurred in the activation peptide region during PCR cloning (Q13R). This construct, harboring three mutations, was used to express the recombinant proteins used in the present study. The protein was heterologously overexpressed in yeast following an approach recently reported for other proproteases (43) . Briefly, the vector pPIC9 containing the mutant gene was transformed into Pichia pastoris strain KM71 by the spheroblast method. After expression at 30°C, the culture supernatant containing pro-hK6 was separated by centrifugation and subjected to two steps of purification (hydrophobic and anion-exchange fast protein liquid chromatography). A final size exclusion chromatography step resulted in highly purified protein, finally concentrated to 10 mg/ml (in 10 mM Tris-HCl, pH 8.5, 10 mM benzamidine). The presence of a single continuous protein chain was assessed by mass spectrometry and automated Edman degradation analysis of the N-terminal sequence. Pro-hK6 was activated to render fully active mature hK6 by trypsin and lysyl endopeptidase cleavage; the active enzyme was tested for activity against the synthetic substrate N ␣ -benzoyl-L-arginine ethyl ester (Sigma). This shows that our pro-hK6 form is not a nonactivable truncated species, as described in the form of subunit III for the serine protease proenzyme proprotease E (44) .
Crystallization and Data Collection-The protein was crystallized using the sitting drop vapor diffusion method from equivolumetric drops of protein and precipitant solution (30% polyethylene glycol 4000, 0. (45)). A cryo-protecting solution consisted of mother liquor with 20% glycerol. Crystals briefly soaked in this solution were immediately flash cryo-cooled in liquid nitrogen and stored for diffraction analysis. Diffraction data collection was performed at European Synchrotron Radiation Facility beamlines (Grenoble, France) with 165-mm marCCD and ADSC Quantum4 CCD detectors. Data were processed with MOSFLM version 6.11b (46) and scaled, merged, and reduced with SCALA (47) . Table I provides a summary for the data collection and processing.
Structure Solution and Refinement-A preliminary search for sequence similarity of pro-hK6 within the Protein Data Bank revealed the closest relationship with murine neuropsin (PDB 1npm (32) ). Accordingly, these coordinates were used as a searching model to solve the structure by molecular replacement, using the stand alone version of AMoRe (48) . These calculations, performed in the 15 to 4.0-Å resolution range, confirmed P2 1 2 1 2 1 as the correct space group. The rotation function (RF) showed a clear peak at Eulerian angles ␣ ϭ 26.7°, ␤ ϭ 87.5°, and ␥ ϭ 74.0°. The correlation coefficient in amplitudes (CC (48)) for this solution equals 3.7%, the crystallographic R factor (see Table I for a definition; computed after data expansion to P 1 ) equals 56.9%, and RF ϭ 9.5 (second highest solution: CC ϭ 1.5%, R factor ϭ 57.2%, RF ϭ The input coordinates were rotated and translated according to this solution and subjected to a simulated annealing refinement step and positional/temperature factor refinement using maximum likelihood as a criterion after performing bulk solvent correction and anisotropic temperature factor refinement (R factor ϭ 41.3%; free R factor ϭ 44.2%). Program CNS version 1.0 (49) was used for this purpose. The subsequently computed A -weighted 2mF o Ϫ DF c and mF o Ϫ DF c electron density maps, inspected together with the initially refined model on a SGI Graphic Work station with the program TURBO-FRODO (50) , showed the correctness of the solution and positive difference density for the regions diverging from the phasing model. At this stage, an electron density/model improvement step was undertaken with ARP/wARP (51) using all data up to 1.8-Å resolution and the warpNtrace-mode with protein sequence information. This calculation rendered excellent electron density maps (see Fig. 2 , a and b) and a model consisting of five chains and 185 residues identified within the sequence. In successive cycles, this model was improved by alternating manual model building and crystallographic refinement with CNS and refmac5 (52) under translations and liberations of pseudo-rigid bodies FIG. 1. Primary and secondary structures of pro-hK6. Shown is a structure-based sequence alignment of members of the kallikrein family of known three-dimensional structure, together with PSA and trypsinogen. Displayed are the zymogen forms (pre and/or pro sequences are boxed) of hK6 (this work; SwissProt/TrEMBL (SP) sequence access code Q92876; kallikrein family ascription number KLK6 (3, 5)), mouse-brain neuropsin (PDB accession code 1npm; SP Q61955; KLK8 (32)), mouse glandular kallikrein 13 (PDB 1ao5; SP P36368; KLK13 (10)), rat glandular tonin (PDB 1ton; SP P00759; KLK2 (9)), mouse neuronal 7S ␥-nerve growth factor (PDB 1sgf; SP P00756; KLK3 (77)), human PSA (SP P07288; KLK3), and bovine pancreatic trypsin (PDB 1tgb; SP P00760 (78) ). The sequence of mature porcine pancreatic kallikrein A (PDB 2pka; SP P00752; KLK1 (67)), for which the sequence upstream of the activation cleavage site has not been reported, is also shown. This protein has been chemically sequenced, so that B in the sequence stands for aspartate/asparagine. The sequential pro-hK6 numbering is shown at the bottom, and the chymotrypsinogenbased numbering (18) , used throughout, is on top. The three introduced amino acid substitutions (Q13R/R76Q/N132Q) in this sequence are shown in boldface type. Regular secondary structure elements correspond to pro-hK6; the arrows represent ␤-strands, and rods represent ␣-helices. The cysteine residues engaged in the formation of up to six disulfide bonds are boxed and marked with labels (SS1-SS6). The 29 "invariant" residues (70) in serine proteinases and the residue in the bottom of the S 1 specificity pocket are shown with a gray background, characteristic residues for kallikreins (67) appear with a rhombus, the N-glycosylation site of hK6 is shown with a square, and the limited proteolysis activation site is indicated by vertical scissors. According to the chymotrypsinogen numbering, this cleavage occurs between residues Arg/Lys 15 and Ile/Leu/Val 16 .
(TLS) refinement (53 electron density map obtained after ARP/wARP refinement, superimposed with the model used for initial phasing, contoured at 1 above average. b, same as a, with the final refined model superimposed. c, stereo ribbon plot of pro-hK6 shown in the traditional serine proteinase standard orientation (79) (i.e. looking into the active site cleft) with a bound substrate running from the left (nonprimed subsites prior to the scissile peptide bond; Ref. 64) to right (primed subsites). The regular secondary structure elements are displayed as arrows (␤-strands) and ribbons (␣-helices) and labeled (␤ 1 -␤ 12 and ␣ 1 -␣ 2 ). The side chains of the residues of the catalytic triad (light gray) and the six disulfide bonds (dark gray; SS1-SS6) are also shown as stick models and labeled. The N and C termini and the positions of characteristic structural loops are also indicated, and poorly defined and undefined main-chain stretches (see "Experimental Procedures") are shown as dark gray coils. larity searches were performed with the DALI server at www.ebi.ac.uk/ dali (56) 
RESULTS AND DISCUSSION
Overall Structure-Pro-hK6 displays a frustum-like shape with approximate overall dimensions of 50 ϫ 45 ϫ 30 Å with a larger flat frontal surface (according to the standard orientation; see Fig. 2c ) and a smaller parallel surface at the back, where the N and C termini are located. It is composed of two hydrophobically interacting domains of about 120 residues, the N-terminal one ranging approximately until Leu 121 and further including Tyr 234 -Ala 244 at the C terminus, and a C-terminal domain from Pro 122 to Arg 233 , both characteristic for the serine proteinase fold (59, 60) . Each domain features a sixstranded antiparallel ␤-barrel, consisting of two intercalating Greek key motifs sharing the two central strands (see Fig. 2c ), and an ␣-helix (␣ 1 belongs to the C-terminal domain and ␣ 2 to the N-terminal one). Strands ␤ 1 -␤ 6 make up the N-terminal ␤-barrel (␤-barrel 1), and ␤ 7 -␤ 12 make up the C-terminal one (␤-barrel 2). The longitudinal axis of ␤-barrel 1 is approximately perpendicular to the frontal frustum back surface, whereas ␤-barrel 2 is almost parallel. At the interface between the barrels on the frontal surface, a shallow depression marks the active site cleft (see below).
The polypeptide chain is covalently cross-linked by six disulfide bridges (SS1-SS6; see Figs. 1 and 2c) . SS1 anchors the N-terminal segment to the C-terminal domain (at ␤ 8 ), and SS2 connects strand ␤ 2 with loop ␤ 3 ␤ 4 , harboring one of the catalytic residues, His 57 (see below), and encompassing a single helical turn between Ala 55 and Cys 58 . SS3-SS6 are located in the C-terminal domain. In particular, SS3 anchors loop ␤ 12 ␣ 2 to the segment connecting both domains on the back surface, SS5 fixes ␣ 1 to the flank of the ␤-barrel moiety and SS6 links the activation segment undergoing major conformational changes upon activation (see below) with the top of the C-terminal barrel.
The N-terminal segment on the surface protrudes from the molecular body (see Fig. 2c ) at the back frustum surface and is only visible in electron density due to inter-main-chain interactions between Lys 15 -Val 17 and His 91 -Pro 92 of a symmetryrelated molecule, as observed in the structure of proprotease E (61). The main chain enters the molecular body at His 27 , leading to the first strand of ␤-barrel 1. Embedded between ␤ 4 and ␤ 5 of this barrel and similarly to other known serine proteinases, a surface-exposed cation-lacking calcium-binding loop (62) Lys 70 -Gln 80 is placed, folded back on top of its flanking strands ␤ 4 and ␤ 5 and approaching loop ␤ 1 ␤ 2 . The tip of Lys 70 occupies the approximate position of a calcium ion in trypsin, which displays metal-coordinating glutamate residues at positions 70 and 80 (see Fig. 1 ). This loop is fully ordered, except for the central residues Ser 78 -Gln 80 , which are flexible. In this region, at the lower right part of the molecule (see Fig. 2c ), an autolysis-sensitive point is located after Arg 76 , which when processed leads to an inactive species. This cleavage was observed during the purification of the protein and may have (auto)regulatory functions as observed in chymotrypsinogen, which is cut during activation at its autolysis loop beside the primary activation point (63) . In order to obtain stable, proteolytically unprocessed protein, this residue was mutated to glutamine in the present study (see "Experimental Procedures" and Fig. 1) .
After leaving ␤-barrel 1, a 26-residue linker (Ala 109 -Thr 134 ) running across the smaller back frustum surface leads to ␤-barrel 2. Before entering its first strand, however, the main chain describes a wide loop, passing over ␤-hairpin ␤ 10 ␤ 11 and harboring at position Asn 132 (mutated to glutamine in the present study) an N-glycosylation site that accounts for additional 9 kDa in the molecular mass of the native protein (16) . After the first strand of ␤-barrel 2 and spatially adjacent to the calciumbinding loop, in the middle lower part of the molecule (Fig. 2c) It is located on the front surface and anchored via SS6 to the previously mentioned base-forming segment. This region is involved in shaping the S 1 pocket (see below). Following this and after passing through strand ␤ 12 , the main chain runs over ␤-barrel 1, reaching the opposite surface and the C terminus in the form of helix ␣ 2 , which packs against the strands of the second Greek key motif of ␤-barrel 1.
Active Site Cleft and Specificity Pocket of Pro-hK6 -The essential residues shaping the active site and the specificity pocket (S 1 site (64)) are provided by the loops connecting the third and fourth and the fifth and sixth ␤-strands of each barrel on the frustum front. The active site cleft is centered on the catalytic residue Ser 195 , which together with residues His 57 and Asp 102 establishes the charge-relay system characteristic of serine proteinases. His 57 and Asp 102 are provided by loops ␤ 3 ␤ 4 and ␤ 5 ␤ 6 , respectively, of ␤-barrel 1, whereas Ser 195 is presented to the active site cleft by the end of the activation segment prior to strand ␤ 10 of ␤-barrel 2 (see Fig. 2c ).
Substrate binding is achieved in mature serine proteinases by the extended segment Ser 214 -Gly 216 (see Fig. 4b ), which binds the peptide main chain via its own main chain, generating an antiparallel ␤-ribbon. The first two residues are in the "active" extended conformation, but the chain deviates at Gly 216 , turning back to cover the S 1 pocket. , residing at the bottom of the pocket in mature enzymes (see below), is flexible in our proenzyme structure but will account for the trypsin-like preference for lysine and arginine residues in P 1 . Asp 194 , which upon activation will become engaged with the newly formed N terminus in an internal salt bridge, is folded outward and interacts with Trp 141 N and is trapped by the end of loop ␤ 1 ␤ 2 and the beginning of strand ␤ 2 in a similar manner as other zymogens like chymotrypsinogen A and C and proproteinase E (61, 65) . Unlike other zymogens like proproteinase E and trypsinogen, however, it is not engaged in a "second triad" (66) , as the positions corresponding to the second histidine and serine residues are Leu 40 and Ala 32 , respectively, in pro-hK6.
Comparison with Related Serine (Pro)Proteinases-Pro-hK6 has the archetypal structure of trypsinogen/chymotrypsinogenlike serine (pro)proteinases, consisting of the two interacting ␤-barrels and the two ␣-helices. These regions, including between 196 and 211 structurally aligned residues, superimpose well in pro-hK6 and neuropsin (49% sequence identity; see Fig.  1 and Table II) , bovine trypsin/trypsinogen (44%), and porcine pancreatic kallikrein (44%), with higher sequence identity than to other kallikreins (40 -42%). The sequence identity with bovine chymotrypsinogen A is significantly lower (38%). Pro-hK6 has chimeric features between the other kallikrein family members and trypsinogen. Unlike most of the former, but similarly to the latter, pro-hK6 lacks the kallikrein loop (see below and Fig. 1 ), important for kallikrein specificity and a point at which the polypeptide is cleaved and where an N-glycosylation site is located in kallikrein A, kallikrein-13, and other family members although not in pro-hK6 (67) . However, only 3 of the 15 human kallikreins have the complete loop, believed to confer specificity for kininogenase activity (5) . The classic kallikreins display five disulfide bonds, a subset of the six found in bovine trypsin, whereas pro-hK6 and most of the recently sequenced members also display the sixth (see Fig. 1 -Gly 226 of pro-hK6 (yellow sticks) with distinct serine proproteases chymotrypsinogen A (PDB 2cga; magenta sticks) and chymotrypsinogen C (PDB 1pyt; cyan) (a) and trypsinogen (PDB 1tgn; green) and proprotease E (PDB 1pyt; dark blue) (b) and with closely related active serine proteinases kallikrein A (PDB 2pka; red) and tonin (PDB 1ton; pink) (c) and neuropsin (PDB 1npm; black) and trypsin (PDB 2ptn; orange) (d). In all cases, the orientation corresponds to that of Fig. 2c , further rotated clockwise ϳ90°. Selected pro-hK6 residues are labeled. changes between the latter two (67). Moreover, like kallikrein A, pro-hK6 has a deletion at position 37 belonging to loop ␤ 1 ␤ 2 , which adopts an equivalent conformation, distinct from trypsin. It also has the characteristic cis-Pro 219 , part of an extended loop forming an enlarged bump from His 217 to Cys 220 , and a specific orientation of the carbonyl-oxygen of cis-Pro 219 , which points out of the pocket in contrast to other serine proteinases (67) . This feature is present in all kallikreins but missing in trypsin (Fig. 1) . When compared with the latter, kallikrein A shows large deviations in the external loops, mostly surrounding the substrate binding site and forming a more compact rampart around it (67) . This contributes to the generally restricted accessibility of the kallikrein substrate-binding site compared with bovine trypsin, possibly to achieve distinct specificity or the prevention of unwanted inhibition by proteinaceous inhibitors targeting trypsin. The specificity determining aspartate at position 189 is common to most kallikreins except PSA, which, like chymotrypsin, has a serine at this position. This explains its dual trypsin-and chymotrypsin-like specificity (68) . Further exceptions are human KLK7 (asparagine), KLK9 (glycine), and KLK15 (glutamate) (5). 27 of the reported "invariant" amino acids (29 -31, depending on the source (59, 69, 70) ) surrounding the active site of trypsin-like serine proteinases and involved in catalysis or substrate anchoring are totally conserved in pro-hK6. Of the other two residues, Leu 155 in trypsin is conservatively exchanged for an isoleucine, as in kallikrein A, and trypsin Pro 161 is not conserved in most of the other kallikrein sequences either (see Fig. 1 ). Despite the similarity mentioned above, the loops and segments connecting the regular secondary structure elements form a completely novel structure (see Fig. 3, a-d , flattened on top of the Cterminal ␤-barrel on its front. The unique orientation of these regions is accompanied by further singularities in the regions corresponding to the so-called autolysis and calcium-binding loops (Fig. 3, a-d) . Although partially undefined, the latter is positioned ϳ10 Å further away (as calculated for Gln 75 C-␣, at the center of the loop) when compared with trypsin(ogen) and with other (also cation-depleted) kallikrein structures. The latter both display remarkably similar main-chain conformations despite the lack of sequence similarity. This distinct arrangement induces the shift of the autolysis loop in pro-hK6, which invades the space released by the calcium-binding loop. The former is unique in being 2 residues shorter than in trypsin and other related serine proteinases (see Fig. 1 ) and even 4 residues shorter than in kallikrein A. This zone shows high conformational variability among serine (pro)proteinases (see Fig. 3 ), although none is as close to the calcium-binding loop as in pro-hK6. On the other side of this loop, these changes lead the end of the base-forming segment (distinct from Ala 183 -Asp 194 ; see Fig. 3, a-d) to occupy the free space. Upon further transmission of these changes, loop Gly 216 -Lys 224 , together with disulfide bond SS6, collapses into the molecule, with a maximum distance of 6 -7 Å for Cys 220 . The surface-located segment Ser 130 -Thr 134 also adopts a distinct conformation (not being involved in any intra-or intermolecular contacts), with a maximum deviation of ϳ7 Å. It is folded toward ␤-hairpin ␤ 10 ␤ 11 at Thr 133 and Ala 131 . This region, including the only glycosylation site at position 132, may play a role in a regulatory autoactivation/autoinactivation mechanism or in promoting sugar-mediated adhesion to cells or other molecules, where its activity is required.
Finally, the final refined structure has a unique rotamer of the side chain of active-site Ser 195 . Two solvent molecules and His 57 N⑀2 coordinate its O␥ atom in a tetrahedral manner. The unique feature resides in the gauche Ϫ conformation of its 1 angle (ϩ67°), rendering a high steric hindrance to the interaction with a substrate scissile peptide bond. The side chain can only approach the substrate if the angle becomes negative (gauche ϩ ), as observed in all other zymogen and active protease structures analyzed (see Fig. 3, a-d ; values oscillate between Ϫ43 and Ϫ96°).
Proposed Activation Mechanism-Pro-hK6 is activated in vivo probably by limited proteolysis of peptide bond Lys 15 -Leu 16 , either autolytically or by another yet unknown proteinase with a compatible expression pattern. As previously mentioned, pro-hK6 displays the closest structural and sequential similarity with neuropsin (see Fig. 4 ), although the base-forming segment Ala 183 -Ser 195 is one residue longer in neuropsin. This causes significant structural changes in this loop and in that of the disulfide-connected segment Gly 216 -Gly 226 , endowing hK6 with a slightly different substrate specificity upon maturation. Both proteins have been detected in mammalian brain (32) and, like other homologues such as myelencephalonspecific protease (71), KLK14 (72) , reelin (73) , spinesin (74) , and neurotrypsin (75) , show higher expression levels in the central nervous system than in most peripheral tissues. A recent report has even shown that high levels of plasma kallikrein are present in the brain, where it could play a role in the nervous system (76) . Both pro-hK6 and neuropsin share, besides a sequence identity of 49%, the absence of the kallikrein loop (see Fig. 1 ) and the presence of the sixth SS bond found in bovine trypsin, although absent in other kallikrein structures. Accordingly, neuropsin, the only brain-associated kallikrein of known structure (32) , can be considered as a valid model for active hK6 and thus suggests which structural rearrangements would possibly occur upon pro-hK6 activation (see above and Fig. 4) .
Thus, upon proteolytic cleavage of the pro-hK6 target bond (Fig. 4c, x) , the new N-terminal segment Leu 16 (Fig. 4c, x) , which would be folded inward with a maximum displacement of ϳ10 Å for Asp 189 C-␣. This is mainly permitted by a ϳ150°rotation around Gly 188A N-C␣, facilitated by the absence of a side chain in this residue, and a further rotation of ϳ130°around Asp 194 C-␣-C. In this way, the acidic side chain of the latter residue would rotate to establish the classical salt bridge with the new N terminus, Leu 16 N, and the oxyanion hole-shaping main-chain nitrogen atom of Gly 193 would be properly positioned. Also, these changes might trigger a ϳ180°rotation of the side chain of active site Ser 195 around its 1 angle to reach the negative value observed in neuropsin and other active serine proteinases. The residue following the N terminus, Val 17 , would be trapped by Asp 189 via a main-chain double hydrogen bond. The further intrusion of the new N terminus would also rearrange the autolysis loop (Fig. 4c, y (Fig. 4c, z) by a ϳ90°rotation around Gly 216 N-C-␣. Furthermore, the rearrangement of the autolysis loop could push out the vicinal calcium-binding loop to adopt the conformation observed in neuropsin (partially undefined in this structure however), but also in kallikrein A, tonin, and kallikrein 13 (see Fig. 3, a-d) . This structural element would be folded out with a maximum displacement of ϳ13 Å for Gln 76 , explaining the susceptibility of this region to autolytic cleavage upon proteolytic activation. In any case, this movement, mainly enabled by a ϳ60°rotation around Leu 73 N-C-␣ and a second of ϳ90°around Glu 81 C-␣-C, would imply the rupture of the strong double main chain hydrogen bond between Leu 73 and Asp 153 observed in pro-hK6. Conclusion-Despite close overall structural similarity with other members of the trypsin/chymotrypsin-like family of serine (pro)proteinases, the structure of pro-hK6 has unique features that mainly affect those regions involved in rearrangement upon activation. The close sequential and structural similarity and tissue distribution of pro-hK6 with mouse neuropsin makes the latter a valid structural model for active human hK6 in the absence of an experimental structure and allows the formulation of a novel activation mechanism. The proposed activation may be achieved either by extrinsic trypsin(-like) activity involving other kallikreins or intrinsically due to a regulatory autoactivation mechanism. In addition to this activation pathway, the autolysis-sensitive position after Arg 76 leads to an inactive species and may provide a second regulatory mechanism; once mature protein has been generated from pro-hK6 in the presence of adequate stimuli and in the proper environment, the capacity for autolysis at this position may provide a complementary autoinactivation strategy, acting when the local concentration of hK6 becomes too high or its activity is no longer required.
